225 related articles for article (PubMed ID: 1744638)
1. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
[TBL] [Abstract][Full Text] [Related]
2. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Blin J; Vidailhet MJ; Pillon B; Dubois B; Feve JR; Agid Y
Mov Disord; 1992 Oct; 7(4):348-54. PubMed ID: 1484530
[TBL] [Abstract][Full Text] [Related]
3. Lid opening apraxia is associated with medial frontal hypometabolism.
Smith D; Ishikawa T; Dhawan V; Winterkorn JS; Eidelberg D
Mov Disord; 1995 May; 10(3):341-4. PubMed ID: 7651454
[TBL] [Abstract][Full Text] [Related]
4. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
[TBL] [Abstract][Full Text] [Related]
5. Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration?
Coulier IM; de Vries JJ; Leenders KL
Mov Disord; 2003 Oct; 18(10):1175-8. PubMed ID: 14534923
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
Gross-Glenn K; Duara R; Barker WW; Loewenstein D; Chang JY; Yoshii F; Apicella AM; Pascal S; Boothe T; Sevush S
J Clin Exp Neuropsychol; 1991 Jul; 13(4):531-44. PubMed ID: 1918284
[TBL] [Abstract][Full Text] [Related]
7. Patterns of cortical activity in schizophrenia.
Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
[TBL] [Abstract][Full Text] [Related]
8. Frontal and parietal metabolic disturbances in unipolar depression.
Biver F; Goldman S; Delvenne V; Luxen A; De Maertelaer V; Hubain P; Mendlewicz J; Lotstra F
Biol Psychiatry; 1994 Sep; 36(6):381-8. PubMed ID: 7803599
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
[TBL] [Abstract][Full Text] [Related]
10. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
[TBL] [Abstract][Full Text] [Related]
11. [Functional significance of calcinosis of the basal ganglia via positron emission tomography].
Staffen W; Karbe H; Rudolf J; Herholz K; Diederich N; Heiss WD
Fortschr Neurol Psychiatr; 1994 Apr; 62(4):119-24. PubMed ID: 8206464
[TBL] [Abstract][Full Text] [Related]
12. Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Hirato M; Ishihara J; Horikoshi S; Shibazaki T; Ohye C
Acta Neurochir Suppl; 1995; 64():5-8. PubMed ID: 8748574
[TBL] [Abstract][Full Text] [Related]
13. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
Eidelberg D; Moeller JR; Dhawan V; Sidtis JJ; Ginos JZ; Strother SC; Cedarbaum J; Greene P; Fahn S; Rottenberg DA
Mov Disord; 1990; 5(3):203-13. PubMed ID: 2117706
[TBL] [Abstract][Full Text] [Related]
14. Cortical glucose metabolism in Parkinson's disease without dementia.
Eberling JL; Richardson BC; Reed BR; Wolfe N; Jagust WJ
Neurobiol Aging; 1994; 15(3):329-35. PubMed ID: 7936057
[TBL] [Abstract][Full Text] [Related]
15. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis.
Galardi G; Perani D; Grassi F; Bressi S; Amadio S; Antoni M; Comi GC; Canal N; Fazio F
Acta Neurol Scand; 1996 Sep; 94(3):172-6. PubMed ID: 8899050
[TBL] [Abstract][Full Text] [Related]
16. Contribution of PET studies in diagnosis of corticobasal degeneration.
Lutte I; Laterre C; Bodart JM; De Volder A
Eur Neurol; 2000; 44(1):12-21. PubMed ID: 10894990
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral glucose metabolism in major depressive disorder.
Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
[TBL] [Abstract][Full Text] [Related]
18. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study.
Ghaemi M; Raethjen J; Hilker R; Rudolf J; Sobesky J; Deuschl G; Heiss WD
Mov Disord; 2002 Jul; 17(4):782-8. PubMed ID: 12210876
[TBL] [Abstract][Full Text] [Related]
19. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.
Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM
J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470
[TBL] [Abstract][Full Text] [Related]
20. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
Matochik JA; Molchan SE; Zametkin AJ; Warden DL; Sunderland T; Cohen RM
Acta Neurol Scand; 1995 Feb; 91(2):153-7. PubMed ID: 7785428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
